
<document id="DBMI.pac74" origId="pac74">
	<sentence id="DBMI.pac74.s0" origId="s0" text="7 DRUG INTERACTIONS\n\nDrugs for which gastric pH can affect bioavailability\n\nBecause of its profound and long lasting inhibition of gastric acid secretion, it is theoretically possible that omeprazole may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (e.g., ketoconazole, ampicillin esters, and iron salts).">
		<entity charOffset="189-200" id="DBMI.pac74.s0.e0" origId="s0.e0" text="omeprazole " type="Active ingredient"/>
		<entity charOffset="353-358" id="DBMI.pac74.s0.e1" origId="s0.e1" text="iron " type="Active ingredient"/>
		<entity charOffset="330-341" id="DBMI.pac74.s0.e2" origId="s0.e2" text="ampicillin " type="Active ingredient"/>
		<entity charOffset="316-329" id="DBMI.pac74.s0.e3" origId="s0.e3" text="ketoconazole " type="Active ingredient"/>
		<pair e1="DBMI.pac74.s0.e0" e2="DBMI.pac74.s0.e1" id="DBMI.pac74.s0.p0" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="iron " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.s0.e0" e2="DBMI.pac74.s0.e2" id="DBMI.pac74.s0.p1" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="ampicillin " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.s0.e0" e2="DBMI.pac74.s0.e3" id="DBMI.pac74.s0.p2" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="ketoconazole " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.s0.e1" e2="DBMI.pac74.s0.e0" id="DBMI.pac74.s0.p3" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s0.e1" e2="DBMI.pac74.s0.e2" id="DBMI.pac74.s0.p4" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s0.e1" e2="DBMI.pac74.s0.e3" id="DBMI.pac74.s0.p5" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s0.e2" e2="DBMI.pac74.s0.e0" id="DBMI.pac74.s0.p6" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s0.e2" e2="DBMI.pac74.s0.e1" id="DBMI.pac74.s0.p7" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s0.e2" e2="DBMI.pac74.s0.e3" id="DBMI.pac74.s0.p8" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s0.e3" e2="DBMI.pac74.s0.e0" id="DBMI.pac74.s0.p9" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s0.e3" e2="DBMI.pac74.s0.e1" id="DBMI.pac74.s0.p10" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s0.e3" e2="DBMI.pac74.s0.e2" id="DBMI.pac74.s0.p11" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentence>
	<sentence id="DBMI.pac74.s1" origId="s1" text="In the clinical trials, antacids were used concomitantly with the administration of omeprazole delayed-release capsules USP."/>
	<sentence id="DBMI.pac74.s2" origId="s2" text="Drugs metabolized by cytochrome P450 (CYP)\n\nOmeprazole can prolong the elimination of diazepam, warfarin and phenytoin, drugs that are metabolized by oxidation in the liver.">
		<entity charOffset="536-547" id="DBMI.pac74.s2.e0" origId="s2.e0" text="Omeprazole " type="Active ingredient"/>
		<entity charOffset="578-587" id="DBMI.pac74.s2.e1" origId="s2.e1" text="diazepam " type="Active ingredient"/>
		<entity charOffset="588-597" id="DBMI.pac74.s2.e2" origId="s2.e2" text="warfarin " type="Active ingredient"/>
		<entity charOffset="601-611" id="DBMI.pac74.s2.e3" origId="s2.e3" text="phenytoin " type="Active ingredient"/>
		<pair e1="DBMI.pac74.s2.e0" e2="DBMI.pac74.s2.e1" id="DBMI.pac74.s2.p0" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="diazepam " precipitant="Omeprazole "/>
		<pair e1="DBMI.pac74.s2.e0" e2="DBMI.pac74.s2.e2" id="DBMI.pac74.s2.p1" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="warfarin " precipitant="Omeprazole "/>
		<pair e1="DBMI.pac74.s2.e0" e2="DBMI.pac74.s2.e3" id="DBMI.pac74.s2.p2" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="phenytoin " precipitant="Omeprazole "/>
		<pair e1="DBMI.pac74.s2.e1" e2="DBMI.pac74.s2.e0" id="DBMI.pac74.s2.p3" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s2.e1" e2="DBMI.pac74.s2.e2" id="DBMI.pac74.s2.p4" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s2.e1" e2="DBMI.pac74.s2.e3" id="DBMI.pac74.s2.p5" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s2.e2" e2="DBMI.pac74.s2.e0" id="DBMI.pac74.s2.p6" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s2.e2" e2="DBMI.pac74.s2.e1" id="DBMI.pac74.s2.p7" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s2.e2" e2="DBMI.pac74.s2.e3" id="DBMI.pac74.s2.p8" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s2.e3" e2="DBMI.pac74.s2.e0" id="DBMI.pac74.s2.p9" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s2.e3" e2="DBMI.pac74.s2.e1" id="DBMI.pac74.s2.p10" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s2.e3" e2="DBMI.pac74.s2.e2" id="DBMI.pac74.s2.p11" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentence>
	<sentence id="DBMI.pac74.s3" origId="s3" text="There have been reports of increased INR and prothrombin time in patients receiving proton pump inhibitors, including omeprazole, and warfarin concomitantly."/>
	<sentence id="DBMI.pac74.s4" origId="s4" text="Increases in INR and prothrombin time may lead to abnormal bleeding and even death."/>
	<sentence id="DBMI.pac74.s5" origId="s5" text="Patients treated with proton pump inhibitors and warfarin may need to be monitored for increases in INR and prothrombin time."/>
	<sentence id="DBMI.pac74.s6" origId="s6" text="Although in normal subjects no interaction with theophylline or propranolol was found, there have been clinical reports of interaction with other drugs metabolized via the cytochrome P450 system (e.g., cyclosporine, disulfiram, benzodiazepines)."/>
	<sentence id="DBMI.pac74.s7" origId="s7" text="Patients should be monitored to determine if it is necessary to adjust the dosage of these drugs when taken concomitantly with omeprazole delayed-release capsules USP.">
		<entity charOffset="1408-1419" id="DBMI.pac74.s7.e0" origId="s7.e0" text="omeprazole " type="Active ingredient"/>
		<entity charOffset="1083-1096" id="DBMI.pac74.s7.e1" origId="s7.e1" text="theophylline " type="Active ingredient"/>
		<entity charOffset="1099-1111" id="DBMI.pac74.s7.e2" origId="s7.e2" text="propranolol " type="Active ingredient"/>
		<entity charOffset="1237-1250" id="DBMI.pac74.s7.e3" origId="s7.e3" text="cyclosporine " type="Active ingredient"/>
		<entity charOffset="1251-1262" id="DBMI.pac74.s7.e4" origId="s7.e4" text="disulfiram " type="Active ingredient"/>
		<pair e1="DBMI.pac74.s7.e0" e2="DBMI.pac74.s7.e1" id="DBMI.pac74.s7.p0" interaction="true" interactionPhraseType="Qualitative" modality="Negative" object="theophylline " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.s7.e0" e2="DBMI.pac74.s7.e2" id="DBMI.pac74.s7.p1" interaction="true" interactionPhraseType="Qualitative" modality="Negative" object="propranolol " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.s7.e0" e2="DBMI.pac74.s7.e3" id="DBMI.pac74.s7.p2" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="cyclosporine " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.s7.e0" e2="DBMI.pac74.s7.e4" id="DBMI.pac74.s7.p3" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="disulfiram " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.s7.e1" e2="DBMI.pac74.s7.e0" id="DBMI.pac74.s7.p4" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s7.e1" e2="DBMI.pac74.s7.e2" id="DBMI.pac74.s7.p5" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s7.e1" e2="DBMI.pac74.s7.e3" id="DBMI.pac74.s7.p6" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s7.e1" e2="DBMI.pac74.s7.e4" id="DBMI.pac74.s7.p7" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s7.e2" e2="DBMI.pac74.s7.e0" id="DBMI.pac74.s7.p8" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s7.e2" e2="DBMI.pac74.s7.e1" id="DBMI.pac74.s7.p9" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s7.e2" e2="DBMI.pac74.s7.e3" id="DBMI.pac74.s7.p10" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s7.e2" e2="DBMI.pac74.s7.e4" id="DBMI.pac74.s7.p11" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s7.e3" e2="DBMI.pac74.s7.e0" id="DBMI.pac74.s7.p12" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s7.e3" e2="DBMI.pac74.s7.e1" id="DBMI.pac74.s7.p13" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s7.e3" e2="DBMI.pac74.s7.e2" id="DBMI.pac74.s7.p14" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s7.e3" e2="DBMI.pac74.s7.e4" id="DBMI.pac74.s7.p15" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s7.e4" e2="DBMI.pac74.s7.e0" id="DBMI.pac74.s7.p16" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s7.e4" e2="DBMI.pac74.s7.e1" id="DBMI.pac74.s7.p17" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s7.e4" e2="DBMI.pac74.s7.e2" id="DBMI.pac74.s7.p18" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s7.e4" e2="DBMI.pac74.s7.e3" id="DBMI.pac74.s7.p19" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentence>
	<sentence id="DBMI.pac74.s8" origId="s8" text="Concomitant administration of omeprazole and voriconazole (a combined inhibitor of CYP2C19 and CYP3A4) resulted in more than doubling of the omeprazole exposure.">
		<entity charOffset="1495-1508" id="DBMI.pac74.s8.e0" origId="s8.e0" text="voriconazole " type="Active ingredient"/>
		<entity charOffset="1480-1491" id="DBMI.pac74.s8.e1" origId="s8.e1" text="omeprazole " type="Active ingredient"/>
		<pair e1="DBMI.pac74.s8.e0" e2="DBMI.pac74.s8.e1" id="DBMI.pac74.s8.p0" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="omeprazole " precipitant="voriconazole "/>
		<pair e1="DBMI.pac74.s8.e1" e2="DBMI.pac74.s8.e0" id="DBMI.pac74.s8.p1" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentence>
	<sentence id="DBMI.pac74.s9" origId="s9" text="Dose adjustment of omeprazole is not normally required."/>
	<sentence id="DBMI.pac74.s10" origId="s10" text="However, in patients with Zollinger-Ellison syndrome, who may require higher doses up to 240 mg/day, dose adjustment may be considered."/>
	<sentence id="DBMI.pac74.s11" origId="s11" text="When voriconazole (400 mg Q12h x 1 day, then 200 mg x 6 days) was given with omeprazole (40 mg once daily x 7 days) to healthy subjects, it significantly increased the steady-state Cmax and AUC0-24 of omeprazole, an average of 2 times (90% CI: 1.8, 2.6) and 4 times (90% CI: 3.3, 4.4) respectively as compared to when omeprazole was given without voriconazole.">
		<entity charOffset="1809-1822" id="DBMI.pac74.s11.e0" origId="s11.e0" text="voriconazole " type="Active ingredient"/>
		<entity charOffset="1881-1892" id="DBMI.pac74.s11.e1" origId="s11.e1" text="omeprazole " type="Active ingredient"/>
		<entity charOffset="2364-2375" id="DBMI.pac74.s11.e2" origId="s11.e2" text="atazanavir " type="Active ingredient"/>
		<pair e1="DBMI.pac74.s11.e0" e2="DBMI.pac74.s11.e1" id="DBMI.pac74.s11.p0" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="omeprazole " precipitant="voriconazole "/>
		<pair e1="DBMI.pac74.s11.e0" e2="DBMI.pac74.s11.e2" id="DBMI.pac74.s11.p1" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s11.e1" e2="DBMI.pac74.s11.e0" id="DBMI.pac74.s11.p2" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s11.e1" e2="DBMI.pac74.s11.e2" id="DBMI.pac74.s11.p3" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="atazanavir " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.s11.e2" e2="DBMI.pac74.s11.e0" id="DBMI.pac74.s11.p4" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s11.e2" e2="DBMI.pac74.s11.e1" id="DBMI.pac74.s11.p5" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentence>
	<sentence id="DBMI.pac74.s12" origId="s12" text="Antiretroviral Agents\n\nConcomitant use of atazanavir and proton pump inhibitors is not recommended."/>
	<sentence id="DBMI.pac74.s13" origId="s13" text="Co-administration of atazanavir with proton pump inhibitors is expected to substantially decrease atazanavir plasma concentrations and thereby reduce its therapeutic effect."/>
	<sentence id="DBMI.pac74.s14" origId="s14" text="Omeprazole has been reported to interact with some antiretroviral drugs."/>
	<sentence id="DBMI.pac74.s15" origId="s15" text="The clinical importance and the mechanisms behind these interactions are not always known."/>
	<sentence id="DBMI.pac74.s16" origId="s16" text="Increased gastric pH during omeprazole treatment may change the absorption of the antiretroviral drug."/>
	<sentence id="DBMI.pac74.s17" origId="s17" text="Other possible interaction mechanisms are via CYP2C19."/>
	<sentence id="DBMI.pac74.s18" origId="s18" text="For some antiretroviral drugs, such as atazanavir and nelfinavir, decreased serum levels have been reported when given together with omeprazole.">
		<entity charOffset="2896-2907" id="DBMI.pac74.s18.e0" origId="s18.e0" text="omeprazole " type="Active ingredient"/>
		<entity charOffset="2817-2828" id="DBMI.pac74.s18.e1" origId="s18.e1" text="nelfinavir " type="Active ingredient"/>
		<entity charOffset="2802-2813" id="DBMI.pac74.s18.e2" origId="s18.e2" text="atazanavir " type="Active ingredient"/>
		<pair e1="DBMI.pac74.s18.e0" e2="DBMI.pac74.s18.e1" id="DBMI.pac74.s18.p0" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="nelfinavir " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.s18.e0" e2="DBMI.pac74.s18.e2" id="DBMI.pac74.s18.p1" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="atazanavir " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.s18.e1" e2="DBMI.pac74.s18.e0" id="DBMI.pac74.s18.p2" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s18.e1" e2="DBMI.pac74.s18.e2" id="DBMI.pac74.s18.p3" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s18.e2" e2="DBMI.pac74.s18.e0" id="DBMI.pac74.s18.p4" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s18.e2" e2="DBMI.pac74.s18.e1" id="DBMI.pac74.s18.p5" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentence>
	<sentence id="DBMI.pac74.s19" origId="s19" text="Following multiple doses of nelfinavir (1250 mg, bid) and omeprazole (40 mg, qd), AUC was decreased by 36% and 92%, Cmax by 37% and 89% and Cmin by 39% and 75% respectively for nelfinavir and M8.">
		<entity charOffset="2966-2977" id="DBMI.pac74.s19.e0" origId="s19.e0" text="omeprazole " type="Active ingredient"/>
		<entity charOffset="3100-3103" id="DBMI.pac74.s19.e1" origId="s19.e1" text="M8 " type="Metabolite"/>
		<entity charOffset="2936-2947" id="DBMI.pac74.s19.e2" origId="s19.e2" text="nelfinavir " type="Active ingredient"/>
		<pair e1="DBMI.pac74.s19.e0" e2="DBMI.pac74.s19.e1" id="DBMI.pac74.s19.p0" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="M8 " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.s19.e0" e2="DBMI.pac74.s19.e2" id="DBMI.pac74.s19.p1" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="nelfinavir " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.s19.e1" e2="DBMI.pac74.s19.e0" id="DBMI.pac74.s19.p2" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s19.e1" e2="DBMI.pac74.s19.e2" id="DBMI.pac74.s19.p3" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s19.e2" e2="DBMI.pac74.s19.e0" id="DBMI.pac74.s19.p4" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s19.e2" e2="DBMI.pac74.s19.e1" id="DBMI.pac74.s19.p5" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentence>
	<sentence id="DBMI.pac74.s20" origId="s20" text="Following multiple doses of atazanavir (400 mg, qd) and omeprazole (40 mg, qd, 2 hr before atazanavir), AUC was decreased by 94%, Cmax by 96%, and Cmin by 95%.">
		<entity charOffset="3160-3171" id="DBMI.pac74.s20.e0" origId="s20.e0" text="omeprazole " type="Active ingredient"/>
		<entity charOffset="3132-3143" id="DBMI.pac74.s20.e1" origId="s20.e1" text="atazanavir " type="Active ingredient"/>
		<pair e1="DBMI.pac74.s20.e0" e2="DBMI.pac74.s20.e1" id="DBMI.pac74.s20.p0" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="atazanavir " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.s20.e1" e2="DBMI.pac74.s20.e0" id="DBMI.pac74.s20.p1" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentence>
	<sentence id="DBMI.pac74.s21" origId="s21" text="Concomitant administration with omeprazole and drugs such as atazanavir and nelfinavir is therefore not recommended."/>
	<sentence id="DBMI.pac74.s22" origId="s22" text="For other antiretroviral drugs, such as saquinavir, elevated serum levels have been reported with an increase in AUC by 82%, in Cmax by 75% and in Cmin by 106% following multiple dosing of saquinavir/ritonavir (1000/100 mg) bid for 15 days with omeprazole 40 mg qd co-administered days 11 to 15.">
		<entity charOffset="3626-3637" id="DBMI.pac74.s22.e0" origId="s22.e0" text="omeprazole " type="Active ingredient"/>
		<entity charOffset="3421-3432" id="DBMI.pac74.s22.e1" origId="s22.e1" text="saquinavir " type="Active ingredient"/>
		<entity charOffset="3581-3591" id="DBMI.pac74.s22.e2" origId="s22.e2" text="ritonavir " type="Active ingredient"/>
		<pair e1="DBMI.pac74.s22.e0" e2="DBMI.pac74.s22.e1" id="DBMI.pac74.s22.p0" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="saquinavir " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.s22.e0" e2="DBMI.pac74.s22.e1" id="DBMI.pac74.s22.p1" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="saquinavir " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.s22.e0" e2="DBMI.pac74.s22.e2" id="DBMI.pac74.s22.p2" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="ritonavir " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.s22.e1" e2="DBMI.pac74.s22.e0" id="DBMI.pac74.s22.p3" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s22.e1" e2="DBMI.pac74.s22.e2" id="DBMI.pac74.s22.p4" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s22.e2" e2="DBMI.pac74.s22.e0" id="DBMI.pac74.s22.p5" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.s22.e2" e2="DBMI.pac74.s22.e1" id="DBMI.pac74.s22.p6" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentence>
	<sentence id="DBMI.pac74.s23" origId="s23" text="Dose reduction of saquinavir should be considered from the safety perspective for individual patients."/>
	<sentence id="DBMI.pac74.s24" origId="s24" text="There are also some antiretroviral drugs of which unchanged serum levels have been reported when given with omeprazole."/>
	<sentence id="DBMI.pac74.s25" origId="s25" text="Tacrolimus\n\nConcomitant administration of omeprazole and tacrolimus may increase the serum levels of tacrolimus. ">
		<entity charOffset="3943-3954" id="DBMI.pac74.s25.e0" origId="s25.e0" text="omeprazole " type="Active ingredient"/>
		<entity charOffset="3958-3969" id="DBMI.pac74.s25.e1" origId="s25.e1" text="tacrolimus " type="Active ingredient"/>
		<pair e1="DBMI.pac74.s25.e0" e2="DBMI.pac74.s25.e1" id="DBMI.pac74.s25.p0" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="tacrolimus " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.s25.e1" e2="DBMI.pac74.s25.e0" id="DBMI.pac74.s25.p1" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentence>
	<sentencespan id="DBMI.pac74.sp0" origId="sp0" text="7 DRUG INTERACTIONS\n\nDrugs for which gastric pH can affect bioavailability\n\nBecause of its profound and long lasting inhibition of gastric acid secretion, it is theoretically possible that omeprazole may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (e.g., ketoconazole, ampicillin esters, and iron salts). In the clinical trials, antacids were used concomitantly with the administration of omeprazole delayed-release capsules USP. Drugs metabolized by cytochrome P450 (CYP)\n\nOmeprazole can prolong the elimination of diazepam, warfarin and phenytoin, drugs that are metabolized by oxidation in the liver.">
		<entity charOffset="189-200" id="DBMI.pac74.sp0.e0" origId="sp0.e0" text="omeprazole " type="Active ingredient"/>
		<entity charOffset="353-358" id="DBMI.pac74.sp0.e1" origId="sp0.e1" text="iron " type="Active ingredient"/>
		<entity charOffset="330-341" id="DBMI.pac74.sp0.e2" origId="sp0.e2" text="ampicillin " type="Active ingredient"/>
		<entity charOffset="316-329" id="DBMI.pac74.sp0.e3" origId="sp0.e3" text="ketoconazole " type="Active ingredient"/>
		<entity charOffset="536-547" id="DBMI.pac74.sp0.e4" origId="sp0.e4" text="Omeprazole " type="Active ingredient"/>
		<entity charOffset="578-587" id="DBMI.pac74.sp0.e5" origId="sp0.e5" text="diazepam " type="Active ingredient"/>
		<entity charOffset="588-597" id="DBMI.pac74.sp0.e6" origId="sp0.e6" text="warfarin " type="Active ingredient"/>
		<entity charOffset="601-611" id="DBMI.pac74.sp0.e7" origId="sp0.e7" text="phenytoin " type="Active ingredient"/>
		<pair e1="DBMI.pac74.sp0.e0" e2="DBMI.pac74.sp0.e1" id="DBMI.pac74.sp0.p0" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="iron " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.sp0.e0" e2="DBMI.pac74.sp0.e2" id="DBMI.pac74.sp0.p1" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="ampicillin " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.sp0.e0" e2="DBMI.pac74.sp0.e3" id="DBMI.pac74.sp0.p2" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="ketoconazole " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.sp0.e0" e2="DBMI.pac74.sp0.e4" id="DBMI.pac74.sp0.p3" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e0" e2="DBMI.pac74.sp0.e5" id="DBMI.pac74.sp0.p4" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e0" e2="DBMI.pac74.sp0.e6" id="DBMI.pac74.sp0.p5" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e0" e2="DBMI.pac74.sp0.e7" id="DBMI.pac74.sp0.p6" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e1" e2="DBMI.pac74.sp0.e0" id="DBMI.pac74.sp0.p7" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e1" e2="DBMI.pac74.sp0.e2" id="DBMI.pac74.sp0.p8" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e1" e2="DBMI.pac74.sp0.e3" id="DBMI.pac74.sp0.p9" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e1" e2="DBMI.pac74.sp0.e4" id="DBMI.pac74.sp0.p10" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e1" e2="DBMI.pac74.sp0.e5" id="DBMI.pac74.sp0.p11" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e1" e2="DBMI.pac74.sp0.e6" id="DBMI.pac74.sp0.p12" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e1" e2="DBMI.pac74.sp0.e7" id="DBMI.pac74.sp0.p13" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e2" e2="DBMI.pac74.sp0.e0" id="DBMI.pac74.sp0.p14" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e2" e2="DBMI.pac74.sp0.e1" id="DBMI.pac74.sp0.p15" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e2" e2="DBMI.pac74.sp0.e3" id="DBMI.pac74.sp0.p16" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e2" e2="DBMI.pac74.sp0.e4" id="DBMI.pac74.sp0.p17" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e2" e2="DBMI.pac74.sp0.e5" id="DBMI.pac74.sp0.p18" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e2" e2="DBMI.pac74.sp0.e6" id="DBMI.pac74.sp0.p19" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e2" e2="DBMI.pac74.sp0.e7" id="DBMI.pac74.sp0.p20" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e3" e2="DBMI.pac74.sp0.e0" id="DBMI.pac74.sp0.p21" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e3" e2="DBMI.pac74.sp0.e1" id="DBMI.pac74.sp0.p22" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e3" e2="DBMI.pac74.sp0.e2" id="DBMI.pac74.sp0.p23" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e3" e2="DBMI.pac74.sp0.e4" id="DBMI.pac74.sp0.p24" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e3" e2="DBMI.pac74.sp0.e5" id="DBMI.pac74.sp0.p25" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e3" e2="DBMI.pac74.sp0.e6" id="DBMI.pac74.sp0.p26" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e3" e2="DBMI.pac74.sp0.e7" id="DBMI.pac74.sp0.p27" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e4" e2="DBMI.pac74.sp0.e0" id="DBMI.pac74.sp0.p28" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e4" e2="DBMI.pac74.sp0.e1" id="DBMI.pac74.sp0.p29" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e4" e2="DBMI.pac74.sp0.e2" id="DBMI.pac74.sp0.p30" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e4" e2="DBMI.pac74.sp0.e3" id="DBMI.pac74.sp0.p31" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e4" e2="DBMI.pac74.sp0.e5" id="DBMI.pac74.sp0.p32" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="diazepam " precipitant="Omeprazole "/>
		<pair e1="DBMI.pac74.sp0.e4" e2="DBMI.pac74.sp0.e6" id="DBMI.pac74.sp0.p33" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="warfarin " precipitant="Omeprazole "/>
		<pair e1="DBMI.pac74.sp0.e4" e2="DBMI.pac74.sp0.e7" id="DBMI.pac74.sp0.p34" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="phenytoin " precipitant="Omeprazole "/>
		<pair e1="DBMI.pac74.sp0.e5" e2="DBMI.pac74.sp0.e0" id="DBMI.pac74.sp0.p35" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e5" e2="DBMI.pac74.sp0.e1" id="DBMI.pac74.sp0.p36" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e5" e2="DBMI.pac74.sp0.e2" id="DBMI.pac74.sp0.p37" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e5" e2="DBMI.pac74.sp0.e3" id="DBMI.pac74.sp0.p38" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e5" e2="DBMI.pac74.sp0.e4" id="DBMI.pac74.sp0.p39" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e5" e2="DBMI.pac74.sp0.e6" id="DBMI.pac74.sp0.p40" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e5" e2="DBMI.pac74.sp0.e7" id="DBMI.pac74.sp0.p41" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e6" e2="DBMI.pac74.sp0.e0" id="DBMI.pac74.sp0.p42" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e6" e2="DBMI.pac74.sp0.e1" id="DBMI.pac74.sp0.p43" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e6" e2="DBMI.pac74.sp0.e2" id="DBMI.pac74.sp0.p44" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e6" e2="DBMI.pac74.sp0.e3" id="DBMI.pac74.sp0.p45" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e6" e2="DBMI.pac74.sp0.e4" id="DBMI.pac74.sp0.p46" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e6" e2="DBMI.pac74.sp0.e5" id="DBMI.pac74.sp0.p47" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e6" e2="DBMI.pac74.sp0.e7" id="DBMI.pac74.sp0.p48" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e7" e2="DBMI.pac74.sp0.e0" id="DBMI.pac74.sp0.p49" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e7" e2="DBMI.pac74.sp0.e1" id="DBMI.pac74.sp0.p50" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e7" e2="DBMI.pac74.sp0.e2" id="DBMI.pac74.sp0.p51" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e7" e2="DBMI.pac74.sp0.e3" id="DBMI.pac74.sp0.p52" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e7" e2="DBMI.pac74.sp0.e4" id="DBMI.pac74.sp0.p53" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e7" e2="DBMI.pac74.sp0.e5" id="DBMI.pac74.sp0.p54" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp0.e7" e2="DBMI.pac74.sp0.e6" id="DBMI.pac74.sp0.p55" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentencespan>
	<sentencespan id="DBMI.pac74.sp1" origId="sp1" text="There have been reports of increased INR and prothrombin time in patients receiving proton pump inhibitors, including omeprazole, and warfarin concomitantly. Increases in INR and prothrombin time may lead to abnormal bleeding and even death. Patients treated with proton pump inhibitors and warfarin may need to be monitored for increases in INR and prothrombin time."/>
	<sentencespan id="DBMI.pac74.sp2" origId="sp2" text="Although in normal subjects no interaction with theophylline or propranolol was found, there have been clinical reports of interaction with other drugs metabolized via the cytochrome P450 system (e.g., cyclosporine, disulfiram, benzodiazepines). Patients should be monitored to determine if it is necessary to adjust the dosage of these drugs when taken concomitantly with omeprazole delayed-release capsules USP. Concomitant administration of omeprazole and voriconazole (a combined inhibitor of CYP2C19 and CYP3A4) resulted in more than doubling of the omeprazole exposure.">
		<entity charOffset="1408-1419" id="DBMI.pac74.sp2.e0" origId="sp2.e0" text="omeprazole " type="Active ingredient"/>
		<entity charOffset="1083-1096" id="DBMI.pac74.sp2.e1" origId="sp2.e1" text="theophylline " type="Active ingredient"/>
		<entity charOffset="1099-1111" id="DBMI.pac74.sp2.e2" origId="sp2.e2" text="propranolol " type="Active ingredient"/>
		<entity charOffset="1237-1250" id="DBMI.pac74.sp2.e3" origId="sp2.e3" text="cyclosporine " type="Active ingredient"/>
		<entity charOffset="1251-1262" id="DBMI.pac74.sp2.e4" origId="sp2.e4" text="disulfiram " type="Active ingredient"/>
		<entity charOffset="1495-1508" id="DBMI.pac74.sp2.e5" origId="sp2.e5" text="voriconazole " type="Active ingredient"/>
		<pair e1="DBMI.pac74.sp2.e0" e2="DBMI.pac74.sp2.e1" id="DBMI.pac74.sp2.p0" interaction="true" interactionPhraseType="Qualitative" modality="Negative" object="theophylline " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.sp2.e0" e2="DBMI.pac74.sp2.e2" id="DBMI.pac74.sp2.p1" interaction="true" interactionPhraseType="Qualitative" modality="Negative" object="propranolol " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.sp2.e0" e2="DBMI.pac74.sp2.e3" id="DBMI.pac74.sp2.p2" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="cyclosporine " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.sp2.e0" e2="DBMI.pac74.sp2.e4" id="DBMI.pac74.sp2.p3" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="disulfiram " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.sp2.e0" e2="DBMI.pac74.sp2.e5" id="DBMI.pac74.sp2.p4" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e1" e2="DBMI.pac74.sp2.e0" id="DBMI.pac74.sp2.p5" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e1" e2="DBMI.pac74.sp2.e2" id="DBMI.pac74.sp2.p6" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e1" e2="DBMI.pac74.sp2.e3" id="DBMI.pac74.sp2.p7" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e1" e2="DBMI.pac74.sp2.e4" id="DBMI.pac74.sp2.p8" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e1" e2="DBMI.pac74.sp2.e5" id="DBMI.pac74.sp2.p9" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e2" e2="DBMI.pac74.sp2.e0" id="DBMI.pac74.sp2.p10" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e2" e2="DBMI.pac74.sp2.e1" id="DBMI.pac74.sp2.p11" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e2" e2="DBMI.pac74.sp2.e3" id="DBMI.pac74.sp2.p12" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e2" e2="DBMI.pac74.sp2.e4" id="DBMI.pac74.sp2.p13" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e2" e2="DBMI.pac74.sp2.e5" id="DBMI.pac74.sp2.p14" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e3" e2="DBMI.pac74.sp2.e0" id="DBMI.pac74.sp2.p15" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e3" e2="DBMI.pac74.sp2.e1" id="DBMI.pac74.sp2.p16" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e3" e2="DBMI.pac74.sp2.e2" id="DBMI.pac74.sp2.p17" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e3" e2="DBMI.pac74.sp2.e4" id="DBMI.pac74.sp2.p18" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e3" e2="DBMI.pac74.sp2.e5" id="DBMI.pac74.sp2.p19" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e4" e2="DBMI.pac74.sp2.e0" id="DBMI.pac74.sp2.p20" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e4" e2="DBMI.pac74.sp2.e1" id="DBMI.pac74.sp2.p21" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e4" e2="DBMI.pac74.sp2.e2" id="DBMI.pac74.sp2.p22" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e4" e2="DBMI.pac74.sp2.e3" id="DBMI.pac74.sp2.p23" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e4" e2="DBMI.pac74.sp2.e5" id="DBMI.pac74.sp2.p24" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e5" e2="DBMI.pac74.sp2.e0" id="DBMI.pac74.sp2.p25" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="omeprazole " precipitant="voriconazole "/>
		<pair e1="DBMI.pac74.sp2.e5" e2="DBMI.pac74.sp2.e1" id="DBMI.pac74.sp2.p26" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e5" e2="DBMI.pac74.sp2.e2" id="DBMI.pac74.sp2.p27" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e5" e2="DBMI.pac74.sp2.e3" id="DBMI.pac74.sp2.p28" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp2.e5" e2="DBMI.pac74.sp2.e4" id="DBMI.pac74.sp2.p29" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentencespan>
	<sentencespan id="DBMI.pac74.sp3" origId="sp3" text="Dose adjustment of omeprazole is not normally required. However, in patients with Zollinger-Ellison syndrome, who may require higher doses up to 240 mg/day, dose adjustment may be considered. When voriconazole (400 mg Q12h x 1 day, then 200 mg x 6 days) was given with omeprazole (40 mg once daily x 7 days) to healthy subjects, it significantly increased the steady-state Cmax and AUC0-24 of omeprazole, an average of 2 times (90% CI: 1.8, 2.6) and 4 times (90% CI: 3.3, 4.4) respectively as compared to when omeprazole was given without voriconazole.">
		<entity charOffset="1809-1822" id="DBMI.pac74.sp3.e0" origId="sp3.e0" text="voriconazole " type="Active ingredient"/>
		<entity charOffset="1881-1892" id="DBMI.pac74.sp3.e1" origId="sp3.e1" text="omeprazole " type="Active ingredient"/>
		<entity charOffset="2364-2375" id="DBMI.pac74.sp3.e2" origId="sp3.e2" text="atazanavir " type="Active ingredient"/>
		<pair e1="DBMI.pac74.sp3.e0" e2="DBMI.pac74.sp3.e1" id="DBMI.pac74.sp3.p0" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="omeprazole " precipitant="voriconazole "/>
		<pair e1="DBMI.pac74.sp3.e0" e2="DBMI.pac74.sp3.e2" id="DBMI.pac74.sp3.p1" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp3.e1" e2="DBMI.pac74.sp3.e0" id="DBMI.pac74.sp3.p2" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp3.e1" e2="DBMI.pac74.sp3.e2" id="DBMI.pac74.sp3.p3" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="atazanavir " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.sp3.e2" e2="DBMI.pac74.sp3.e0" id="DBMI.pac74.sp3.p4" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp3.e2" e2="DBMI.pac74.sp3.e1" id="DBMI.pac74.sp3.p5" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentencespan>
	<sentencespan id="DBMI.pac74.sp4" origId="sp4" text="Antiretroviral Agents\n\nConcomitant use of atazanavir and proton pump inhibitors is not recommended. Co-administration of atazanavir with proton pump inhibitors is expected to substantially decrease atazanavir plasma concentrations and thereby reduce its therapeutic effect. Omeprazole has been reported to interact with some antiretroviral drugs."/>
	<sentencespan id="DBMI.pac74.sp5" origId="sp5" text="The clinical importance and the mechanisms behind these interactions are not always known. Increased gastric pH during omeprazole treatment may change the absorption of the antiretroviral drug. Other possible interaction mechanisms are via CYP2C19."/>
	<sentencespan id="DBMI.pac74.sp6" origId="sp6" text="For some antiretroviral drugs, such as atazanavir and nelfinavir, decreased serum levels have been reported when given together with omeprazole. Following multiple doses of nelfinavir (1250 mg, bid) and omeprazole (40 mg, qd), AUC was decreased by 36% and 92%, Cmax by 37% and 89% and Cmin by 39% and 75% respectively for nelfinavir and M8. Following multiple doses of atazanavir (400 mg, qd) and omeprazole (40 mg, qd, 2 hr before atazanavir), AUC was decreased by 94%, Cmax by 96%, and Cmin by 95%.">
		<entity charOffset="2896-2907" id="DBMI.pac74.sp6.e0" origId="sp6.e0" text="omeprazole " type="Active ingredient"/>
		<entity charOffset="2817-2828" id="DBMI.pac74.sp6.e1" origId="sp6.e1" text="nelfinavir " type="Active ingredient"/>
		<entity charOffset="2802-2813" id="DBMI.pac74.sp6.e2" origId="sp6.e2" text="atazanavir " type="Active ingredient"/>
		<entity charOffset="3100-3103" id="DBMI.pac74.sp6.e3" origId="sp6.e3" text="M8 " type="Metabolite"/>
		<pair e1="DBMI.pac74.sp6.e0" e2="DBMI.pac74.sp6.e1" id="DBMI.pac74.sp6.p0" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="nelfinavir " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.sp6.e0" e2="DBMI.pac74.sp6.e1" id="DBMI.pac74.sp6.p1" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="nelfinavir " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.sp6.e0" e2="DBMI.pac74.sp6.e2" id="DBMI.pac74.sp6.p2" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="atazanavir " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.sp6.e0" e2="DBMI.pac74.sp6.e2" id="DBMI.pac74.sp6.p3" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="atazanavir " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.sp6.e0" e2="DBMI.pac74.sp6.e3" id="DBMI.pac74.sp6.p4" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="M8 " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.sp6.e1" e2="DBMI.pac74.sp6.e0" id="DBMI.pac74.sp6.p5" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp6.e1" e2="DBMI.pac74.sp6.e2" id="DBMI.pac74.sp6.p6" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp6.e1" e2="DBMI.pac74.sp6.e3" id="DBMI.pac74.sp6.p7" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp6.e2" e2="DBMI.pac74.sp6.e0" id="DBMI.pac74.sp6.p8" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp6.e2" e2="DBMI.pac74.sp6.e1" id="DBMI.pac74.sp6.p9" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp6.e2" e2="DBMI.pac74.sp6.e3" id="DBMI.pac74.sp6.p10" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp6.e3" e2="DBMI.pac74.sp6.e0" id="DBMI.pac74.sp6.p11" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp6.e3" e2="DBMI.pac74.sp6.e1" id="DBMI.pac74.sp6.p12" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp6.e3" e2="DBMI.pac74.sp6.e2" id="DBMI.pac74.sp6.p13" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentencespan>
	<sentencespan id="DBMI.pac74.sp7" origId="sp7" text="Concomitant administration with omeprazole and drugs such as atazanavir and nelfinavir is therefore not recommended. For other antiretroviral drugs, such as saquinavir, elevated serum levels have been reported with an increase in AUC by 82%, in Cmax by 75% and in Cmin by 106% following multiple dosing of saquinavir/ritonavir (1000/100 mg) bid for 15 days with omeprazole 40 mg qd co-administered days 11 to 15. Dose reduction of saquinavir should be considered from the safety perspective for individual patients.">
		<entity charOffset="3626-3637" id="DBMI.pac74.sp7.e0" origId="sp7.e0" text="omeprazole " type="Active ingredient"/>
		<entity charOffset="3421-3432" id="DBMI.pac74.sp7.e1" origId="sp7.e1" text="saquinavir " type="Active ingredient"/>
		<entity charOffset="3581-3591" id="DBMI.pac74.sp7.e2" origId="sp7.e2" text="ritonavir " type="Active ingredient"/>
		<pair e1="DBMI.pac74.sp7.e0" e2="DBMI.pac74.sp7.e1" id="DBMI.pac74.sp7.p0" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="saquinavir " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.sp7.e0" e2="DBMI.pac74.sp7.e1" id="DBMI.pac74.sp7.p1" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="saquinavir " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.sp7.e0" e2="DBMI.pac74.sp7.e2" id="DBMI.pac74.sp7.p2" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="ritonavir " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.sp7.e1" e2="DBMI.pac74.sp7.e0" id="DBMI.pac74.sp7.p3" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp7.e1" e2="DBMI.pac74.sp7.e2" id="DBMI.pac74.sp7.p4" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp7.e2" e2="DBMI.pac74.sp7.e0" id="DBMI.pac74.sp7.p5" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac74.sp7.e2" e2="DBMI.pac74.sp7.e1" id="DBMI.pac74.sp7.p6" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentencespan>
	<sentencespan id="DBMI.pac74.sp8" origId="sp8" text="There are also some antiretroviral drugs of which unchanged serum levels have been reported when given with omeprazole. Tacrolimus\n\nConcomitant administration of omeprazole and tacrolimus may increase the serum levels of tacrolimus. ">
		<entity charOffset="3943-3954" id="DBMI.pac74.sp8.e0" origId="sp8.e0" text="omeprazole " type="Active ingredient"/>
		<entity charOffset="3958-3969" id="DBMI.pac74.sp8.e1" origId="sp8.e1" text="tacrolimus " type="Active ingredient"/>
		<pair e1="DBMI.pac74.sp8.e0" e2="DBMI.pac74.sp8.e1" id="DBMI.pac74.sp8.p0" interaction="true" interactionPhraseType="Qualitative" modality="Positive" object="tacrolimus " precipitant="omeprazole "/>
		<pair e1="DBMI.pac74.sp8.e1" e2="DBMI.pac74.sp8.e0" id="DBMI.pac74.sp8.p1" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentencespan>
</document>
